1-3 of 3
Véronique Diéras
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Free
Nancy U. Lin, Véronique Diéras, Devchand Paul, Dominique Lossignol, Christos Christodoulou, Hans-Joachim Stemmler, Henri Roché, Minetta C. Liu, Richard Greil, Eva Ciruelos, Sibylle Loibl, Stefania Gori, Andrew Wardley, Denise Yardley, Adam Brufsky, Joanne L. Blum, Stephen D. Rubin, Bernie Dharan, Klaudia Steplewski, Denise Zembryki, Cristina Oliva, Debasish Roychowdhury, Paolo Paoletti, Eric P. Winer
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1452–1459.
https://doi.org/10.1158/1078-0432.CCR-08-1080
Published: 19 February 2009
View articletitled, Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
Open the PDF for Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays

Free
Elisabetta Marangoni, Anne Vincent-Salomon, Nathalie Auger, Armelle Degeorges, Franck Assayag, Patricia de Cremoux, Ludmilla de Plater, Charlotte Guyader, Gonzague De Pinieux, Jean-Gabriel Judde, Magali Rebucci, Carine Tran-Perennou, Xavier Sastre-Garau, Brigitte Sigal-Zafrani, Olivier Delattre, Véronique Diéras, Marie-France Poupon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3989–3998.
https://doi.org/10.1158/1078-0432.CCR-07-0078
Published: 02 July 2007
View articletitled, A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays
Open the PDF for A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays in another window
Journal Articles

Phase I Combining a P-Glycoprotein Inhibitor, MS209, in Combination with Docetaxel in Patients with Advanced Malignancies

Free
Véronique Diéras, Jacques Bonneterre, Valérie Laurence, Marian Degardin, Jean-Yves Pierga, Marie-Edith Bonneterre, Sandrine Marreaud, Denis Lacombe, Pierre Fumoleau
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6256–6260.
https://doi.org/10.1158/1078-0432.CCR-04-2316
Published: 06 September 2005
View articletitled, Phase I Combining a P-Glycoprotein Inhibitor, MS209, in Combination with Docetaxel in Patients with Advanced Malignancies
Open the PDF for Phase I Combining a P-Glycoprotein Inhibitor, MS209, in Combination with Docetaxel in Patients with Advanced Malignancies in another window